The APHL-CDC Antimicrobial Resistance (AR) Laboratory Fellowship Program (AR Lab Fellowship) provides scientists with the opportunity to collaborate on a range of antimicrobial resistance issues. The fellowship's mission is to introduce scientists to public health laboratory science while building the workforce needed to detect and respond to existing and emerging forms of AR.
The AR Lab Fellowship is a full-time working fellowship program for master's- and doctoral-degree level scientists. Fellows will be placed in one of seven public health laboratories for a 12-month term. Extensions for an additional 12-month term may be granted to doctoral fellows, provided funding is available. In addition to laboratory-specific work, fellows will participate in distance-based training and learning activities to achieve proficiency in select public health laboratory
There are two fellowship tracks. The Antibiotic Resistance Laboratory Track is offered each year. The Drug-resistant Tuberculosis (TB) Track is available every other year; recruitment for that track will begin in Fall 2020 for a start date in Summer 2021.
Fellows selected for both the AR Lab Network Track and the Drug-resistant TB Track are required to participate in an orientation session at CDC during the summer they begin their fellowships.
* Laboratories may not have a doctoral fellowship position available during this application period
Masters fellows will have the opportunity to complete the fellowship at other non-regional laboratories of the AR Lab Network, which will be determined through a competitive process.
Drug-resistant Tuberculosis Track
Multidrug-resistant TB is a disease of grave domestic and global public health concern. Rapid and accurate identification of drug resistance is imperative both to ensure appropriate treatment for individual patients as well as the administration of necessary TB Control measures. Fellows participating in the TB Track work with public health leaders to perform and apply conventional, culture-based and cutting edge, molecular methods to identify and control
drug resistant TB outbreaks. The fellow will be primarily placed at the
Michigan Department of Health and Human Services Bureau of Laboratories and will complete periodic rotations at CDC and other public health laboratories.
Fellows receive a stipend and allowances
for: medical insurance, travel to the host laboratory, professional development, training at CDC, and complimentary student membership to APHL. The 2019 stipend follows the
federal General Schedule (GS) pay table. Post-masters will receive compensation commensurate to GS-9 step 1 and post-doctoral fellows receiving compensation commensurate to GS-11 step 1.
Applicants must be US citizens or permanent residents. Applicants must have completed a master's or doctoral degree in microbiology, molecular biology, or a related discipline by the start date of the fellowship.
The online application includes submission of a narrative statement, resume or CV, three
letters of recommendation, official transcripts from all degree-granting institutions, and proof of US citizenship or permanent residency. It is the responsibility of the applicant to ensure all materials are received by APHL by the application deadline. Applications that are incomplete or received after the deadline will not be considered. Finalists will be invited to interview with host laboratories.
November 1, 2019
Online applications available for prospective fellows
March 7, 2020
Deadline for receipt of
application and supplemental materials to APHL
April 30, 2020
All applicants notified of status. Finalists invited to interview
April – May 2020
Fellows report to host laboratories and begin
Due to the ongoing COVID-19 response, the timeline of events may experience slight delays.
Host Laboratory Application
View a list of
about the program and the application
process. If you have additional questions, please contact
Marchan, MPH, specialist, Antimicrobial Resistance, or
Kelly Wroblewski, MPH, MT(ASCP), director, Infectious Disease